Which has the lower trailing P/E, ATRC or TMDX?

TMDX has the lower trailing P/E: ATRC trades at 258.06 and TMDX at 21.14. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ATRC or TMDX?

Over the past five years, TMDX grew revenue faster — ATRC at a 18.57% CAGR versus TMDX at 86.12%.

Is ATRC or TMDX more profitable?

TMDX runs the higher net margin — ATRC at 1.85% versus TMDX at 22.69%.

How have ATRC and TMDX total returns compared?

Over the past 5 years, ATRC delivered -4.06% and TMDX delivered 21.77% annualized total return. Past performance doesn't predict future results.

AtriCure, Inc. (ATRC) vs TransMedics Group, Inc. (TMDX)

A side-by-side comparison of AtriCure, Inc. and TransMedics Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ATRC

AtriCure, Inc.

$2.79B

$54.76HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT

TMDX

TransMedics Group, Inc.

$2.82B

$81.60HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT

Total return — ATRC vs TMDX

growth of $100 · dividends reinvested · last 7y

ATRC +90.5% (+9.6%/yr)TMDX +271.2% (+20.6%/yr)TMDX compounded faster over this window

ATRC TMDX

ATRC vs TMDX: by the numbers

•TMDX is the larger company ($2.82B vs $2.79B market cap).
•TMDX trades at the lower trailing earnings multiple (21.14 vs 258.06 P/E), one valuation lens rather than an overall verdict.
•TMDX converts more revenue to profit (22.69% vs 1.85% net margin).
•TMDX grew revenue faster over the past five years (86.12% vs 18.57% CAGR).

Metrics side by side

Valuation

Metric	ATRC	TMDX
P/E ratio	258.06	21.14
Forward P/E	N/A	55.62
P/S ratio	4.89	4.22
P/B ratio	5.39	5.44
EV / EBITDA	77.38	27.24
FCF yield	1.84%	2.80%

Profitability

Metric	ATRC	TMDX
Gross margin	76.16%	58.69%
Operating margin	2.44%	12.21%
Net margin	1.85%	22.69%
ROE	2.04%	29.28%
ROIC	2.04%	5.87%

Growth (annualized)

Metric	ATRC	TMDX
Revenue CAGR (5Y)	18.57%	86.12%
Total return CAGR (5Y)	-4.06%	21.77%

Frequently asked

Which has the lower trailing P/E, ATRC or TMDX?: TMDX has the lower trailing P/E: ATRC trades at 258.06 and TMDX at 21.14. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ATRC or TMDX?: Over the past five years, TMDX grew revenue faster — ATRC at a 18.57% CAGR versus TMDX at 86.12%.
Is ATRC or TMDX more profitable?: TMDX runs the higher net margin — ATRC at 1.85% versus TMDX at 22.69%.
How have ATRC and TMDX total returns compared?: Over the past 5 years, ATRC delivered -4.06% and TMDX delivered 21.77% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ATRC analysis Full TMDX analysis Interactive comparison tool

Dig into the metrics

AtriCure P/E ratio TransMedics P/E ratio AtriCure ROE TransMedics ROE AtriCure operating margin TransMedics operating margin AtriCure revenue growth TransMedics revenue growth AtriCure free cash flow TransMedics free cash flow

AtriCure & TransMedics appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.